Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
One million Americans currently have Parkinson's disease, and another 90,000 are diagnosed with it each year. It is currently the second most prevalent neurodegenerative disease in the country. And it's moving up to No. 1. However, few people are familiar with Parkinson's.
Read Full NewsA phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.
Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.
Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.
A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.
Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.
Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.
Research is limited, but what has been done shows a possible connection.
1.
Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.
2.
Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.
3.
Medicaid expansion tied to smaller declines in early-stage cancer detection
4.
In cancer survivors, loneliness is associated with a higher risk of death.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
2.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
3.
Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction
4.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
5.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge